ProPhase Labs, Inc.
PRPH
$0.05
$0.0120.05%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 44.21% | 72.37% | -50.25% | -57.55% | -82.79% |
| Total Depreciation and Amortization | -32.36% | -23.86% | -14.52% | -9.40% | -4.07% |
| Total Amortization of Deferred Charges | 211.01% | 252.59% | 127.41% | 329.98% | 581.35% |
| Total Other Non-Cash Items | -24.59% | -128.97% | 374.38% | 306.97% | 47.06% |
| Change in Net Operating Assets | -68.07% | -101.24% | 317.68% | 796.55% | 374.73% |
| Cash from Operations | 63.81% | 52.42% | 28.03% | 27.32% | 9.85% |
| Capital Expenditure | -- | -- | 96.38% | 97.80% | 98.40% |
| Sale of Property, Plant, and Equipment | -71.99% | -47.60% | -47.60% | 32.67% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | -74.19% | -60.55% | -80.56% | -88.31% |
| Cash from Investing | -90.60% | -62.01% | -26.54% | -51.87% | -69.09% |
| Total Debt Issued | 5.84% | -23.20% | -4.70% | 85.65% | 209.19% |
| Total Debt Repaid | 49.83% | -0.28% | -131.66% | -561.26% | -2,912.43% |
| Issuance of Common Stock | -97.05% | -53.15% | 41.18% | 12.09% | 806.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | -103.58% | 6,093.75% | 9,630.00% | 23,775.00% |
| Cash from Financing | -59.75% | -51.81% | -27.80% | -24.99% | 118.21% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 94.76% | 36.84% | 52.24% | 21.18% | 87.12% |